$BFRI - Biofrontera Inc. Announces Enrollment of First Subject in Phase 2b Clinical Trial Evaluating Ameluz® + BF-RhodoLED® in Moderate-to-Severe Acne: https://finance.yahoo.com/news/biofrontera-inc-announces-enrollment-first-140900382.html
$PTPI - Petros Pharmaceuticals Announces Positive Over-the-Counter (OTC) Label Comprehension Study Results for Erectile Dysfunction Drug STENDRA® (avanafil) (12/08/2021): https://finance.yahoo.com/news/petros-pharmaceuticals-announces-positive-over-141500031.html